Bio-Rad Laboratories, Inc. (BIO) Research

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Market snapshot

Symbol
BIO
Price
$282.44
Day change
-0.78%
Market cap
$7.6B
P/E ratio
45.11x
52-week range
228.4-343.12
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 1 month
Analyst price target
$321.67

Recent news

  • Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports

    Activist investor Elliott Investment Management has built a sizeable stake ​in U.S. diagnostics supplier Bio-Rad Laboratories , and plans ‌to push the company to boost its underperforming stock price, the Wall Street Journal reported on Sunday.

  • Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad

    Elliott also has a stake in German lab-equipment supplier Sartorius, where Bio-Rad is also an investor.

Peer companies

  • Align Technology, Inc. (ALGN)
  • AptarGroup, Inc. (ATR)
  • Charles River Laboratories International, Inc. (CRL)
  • DaVita Inc. (DVA)
  • Globus Medical, Inc. (GMED)
  • Grifols, S.A. (GRFS)
  • HealthEquity, Inc. (HQY)
  • Henry Schein, Inc. (HSIC)

Recent insider activity

  • ENGELHARDT EVA ANETTE — S-Sale (550 shares) on 2026-05-11
  • Lakkaraju Roop Kalyan — M-Exempt (1078 shares) on 2026-04-24
  • Lakkaraju Roop Kalyan — F-InKind (420 shares) on 2026-04-24
  • Lakkaraju Roop Kalyan — M-Exempt (1078 shares) on 2026-04-24
  • ENLOE COURTNEY C — M-Exempt (186 shares) on 2026-04-24

Open Bio-Rad Laboratories, Inc. (BIO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.